Final answer:
The expected finding for a COPD client receiving nebulized acetylcysteine would be that the mucus is thin and white in color, indicating effective reduction in mucus viscosity and improved lung function.
Step-by-step explanation:
The student has asked about the expected findings when a client with COPD is receiving nebulized acetylcysteine and its effectiveness. Acetylcysteine is a medication used to help thin and loosen mucus in the airways, making it easier for the patient to cough it out. Therefore, the expected finding if the medication has been effective would be option D: Mucus is thin and white in color.
This observation would indicate that the acetylcysteine is serving its purpose by reducing the viscosity of the mucus, hence improving lung defenses and facilitating better respiratory function. It is important to note that acetylcysteine might induce coughing to expel the thinned mucus but generally does not suppress cough, therefore option A would be incorrect. Also, acetylcysteine does not have a direct effect on white blood cell counts or blood glucose levels, making options B and C incorrect.